AstraZeneca India

Amit Agarwal explains how Howden India developed a cancer care policy for employers, while AstraZeneca India integrates it into…

Approval expands indication for Trastuzumab Deruxtecan in combination with Pertuzumab for adults with unresectable or metastatic…

It is now the first anti-complement therapy authorised in India for the treatment of for atypical Haemolytic Uremic Syndrome(aHUS)…

The approval follows evidence from the Phase III LAURA trial, which demonstrated significant clinical benefits in delaying disease…

Durvalumab in combination with chemotherapy as neoadjuvant treatment, followed by Durvalumab as monotherapy after surgery, is…

AstraZeneca will retain the intellectual property rights to budesonide and formoterol fumarate dihydrate and will continue to be…

Mina Patel, Head of Operations, AstraZeneca India, finds that listening to mentees, giving constructive feedback, and not…

AstraZeneca completed the acquisition of Alexion in the year 2021 and is now expanding its portfolio globally to bring innovative…

Panchal has been with AstraZeneca for 19 years and began his career in India back in 2003 as a Brand Associate

The CDI team in Bengaluru, India, is a critical advancement to support a growing global portfolio, and build on internal data…